| Identification of the breast cancer susceptibility gene BRCA2 R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, ... Nature 378, 789-792, 1995 | 4957 | 1995 |
| Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families D Ford, DF Easton, M Stratton, S Narod, D Goldgar, P Devilee, DT Bishop, ... The American Journal of Human Genetics 62 (3), 676-689, 1998 | 3997 | 1998 |
| Breast and Ovarian Cancer Incidence in BRCA1 Mutation Carriers DF Easton, D Ford, DT Bishop, N Haites, B Milner, L Allan, BAJ Ponder, ... Am. J. Hum. Genet. 56, 265-271, 1995 | 2199 | 1995 |
| Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) N Mavaddat, D Barrowdale, IL Andrulis, SM Domchek, D Eccles, ... Cancer Epidemiology, Biomarkers & Prevention 21 (1), 134-147, 2012 | 808 | 2012 |
| Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ... Jama 313 (13), 1347-1361, 2015 | 592 | 2015 |
| A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general … AC Antoniou, X Wang, ZS Fredericksen, L McGuffog, R Tarrell, ... Nature genetics 42 (10), 885-892, 2010 | 410 | 2010 |
| Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations TR Rebbeck, TM Friebel, E Friedman, U Hamann, D Huo, A Kwong, ... Human mutation 39 (5), 593-620, 2018 | 334 | 2018 |
| High prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patients G Johannesdottir, J Gudmundsson, JT Bergthorsson, A Arason, ... Cancer research 56 (16), 3663-3665, 1996 | 321 | 1996 |
| Identification of six new susceptibility loci for invasive epithelial ovarian cancer KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ... Nature genetics 47 (2), 164-171, 2015 | 320 | 2015 |
| RAD51 135G→ C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies AC Antoniou, OM Sinilnikova, J Simard, M Léoné, M Dumont, ... The American Journal of Human Genetics 81 (6), 1186-1200, 2007 | 309 | 2007 |
| Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics G Jönsson, J Staaf, J Vallon-Christersson, M Ringnér, K Holm, C Hegardt, ... Breast Cancer Research 12, 1-14, 2010 | 253 | 2010 |
| Identification of subtypes in human epidermal growth factor receptor 2–positive breast cancer reveals a gene signature prognostic of outcome J Staaf, M Ringnér, J Vallon-Christersson, G Jönsson, PO Bendahl, ... Journal of Clinical Oncology 28 (11), 1813-1820, 2010 | 229 | 2010 |
| Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus T Kainu, SHH Juo, R Desper, AA Schäffer, E Gillanders, E Rozenblum, ... Proceedings of the National Academy of Sciences 97 (17), 9603-9608, 2000 | 223 | 2000 |
| Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12–q13 J Gudmundsson, G Johannesdottir, JT Bergthorsson, A Arason, ... Cancer research 55 (21), 4830-4832, 1995 | 216 | 1995 |
| Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores J Lecarpentier, V Silvestri, KB Kuchenbaecker, D Barrowdale, J Dennis, ... Journal of Clinical Oncology 35 (20), 2240-2250, 2017 | 199 | 2017 |
| Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes L Fachal, H Aschard, J Beesley, DR Barnes, J Allen, S Kar, KA Pooley, ... Nature genetics 52 (1), 56-73, 2020 | 181 | 2020 |
| High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer J Staaf, G Jönsson, M Ringnér, J Vallon-Christersson, D Grabau, ... Breast Cancer Research 12, 1-18, 2010 | 166 | 2010 |
| Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Icelandic families, and possible relationship to prostatic cancer. A Arason, RB Barkardottir, V Egilsson American journal of human genetics 52 (4), 711, 1993 | 164 | 1993 |
| Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk MM Gaudet, KB Kuchenbaecker, J Vijai, RJ Klein, T Kirchhoff, L McGuffog, ... PLoS genetics 9 (3), e1003173, 2013 | 161 | 2013 |
| High allele loss rates at I7q I2‐q2I in breast and ovarian tumors from BRCAI‐linked families RS Cornelis, SL Neuhausen, O Johansson, A Arason, D Kelsell, ... Genes, Chromosomes and Cancer 13 (3), 203-210, 1995 | 154 | 1995 |
